Herrlin, K., Segerdahl, M., Gustafsson, L. L., & Kalso, E. (2000). Methadone, ciprofloxacin, and adverse drug reactions . The Lancet, 356(9247; 16.12.2000), 2069–2070.
Abstract: Ciprofloxacin, given to a patient successfully treated with methadone for more than 6 years, caused profound sedation, confusion, and respiratory depression. We suggest that this was caused by ciprofloxacin inhibition of CYP1A2 and CYP3A4 activity, two of the cytochrome p450 isozymes involved in the metabolism of methadone.
Keywords: treatment and maintenance; methadone; ciprofloxacin; adverse drug effect
|
various. (2012). Spectra Nr. 91 : Gesundheit im Gefängnis. Spectra : Gesundheitsförderung und Prävention, (91; 03/2012), 12.
Keywords: health; health-related behavior; AOD use, abuse, and dependence; prison-based health service; prison-based prevention; prevention; vaccination; Switzerland
|
McElhatton, P. R., Bateman, D. N., Evans, C., Pughe, K. R., & Thomas, S. H. L. (1999). Congenital anomalies after prenatal ecstasy exposure. The Lancet, 354(9188; 23.10.1999), 1441–1442.
Abstract: Prospective follow-up of 136 babies exposed to ecstasy in utero indicated that the drug may be associated with a significantly increased risk of congenital defects (15·4% [95% CI 8·2—25·4]). Cardiovascular anomalies (26 per 1000 livebirths [3·0—9·0]) and musculoskeletal anomalies (38 per 1000 [8·0—109·0]) were predominant.
Keywords: health promotion; addiction; AOD dependence; chemical addiction; ecstasy
|
various. (2012). Spectra no. 91 : La santé en milieu carcéral. Spectra : prévention et promotion de la santé, (90; 03/2012), 12.
Keywords: health; health-related behavior; AOD use, abuse, and dependence; prison-based health service; prison-based prevention; prevention; vaccination; Switzerland
|
various. (2012). Spectra No. 91 : Prison health. Spectra : prevention and health promotion, (90; 03/2012), 12.
Keywords: health; health-related behavior; AOD use, abuse, and dependence; prison-based health service; prison-based prevention; prevention; vaccination; Switzerland
|
various. (2012). Spectra Nr. 90 : Sexuelle und reproduktive Gesundheit. Spectra : Gesundheitsförderung und Prävention, (90; 01/2012), 12.
Keywords: health; health-related behavior; nutrition; woman; HIV infection; Aids; political process
|
various. (2012). Spectra no. 90 : Santé sexuelle et reproductive. Spectra : prévention et promotion de la santé, (90; 01/2012), 12.
Keywords: health; health-related behavior; nutrition; woman; HIV infection; Aids; political process
|
various. (2012). Spectra No. 90 : Sexual and reproductive health. Spectra : prevention and health promotion, (90; 01/2012), 12.
Keywords: health; health-related behavior; nutrition; woman; HIV infection; Aids; political process
|
Ashton, M. (2003). Hepatitis C and needle exchange. Drug and alcohol findings, 2003(9), 24–32.
Keywords: harm reduction; needle distribution and exchange; viral hepatitis; hepatitis C; HIV infection; international area; Malmö; Tacoma; Seattle; Vancouver; Montreal; Amsterdam; study
|
Pierre, J. M. (2011). Cannabis, synthetic cannabinoids, and psychosis risk : What the evidence says. Current Psychiatry, 10(9), 49–57.
Abstract: Over the past 50 years, anecdotal reports linking cannabis sativa (marijuana) and psychosis have been steadily accumulating, giving rise to the notion of “cannabis psychosis.” Despite this historic connection, marijuana often is regarded as a “soft drug” with few harmful effects. However, this benign view is now being revised, along with mounting research demonstrating a clear association between cannabis and psychosis. In this article, I review evidence on marijuana’s impact on the risk of developing psychotic disorders, as well as the potential contributions of “medical” marijuana and other legally available products containing synthetic cannabinoids to psychosis risk.
Keywords: risk factors; schizophrenia; etiology; cannabis; study
|
